{"name": "Aragon Pharmaceuticals",
 "permalink": "aragon-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/aragon-pharmaceuticals",
 "homepage_url": "http://www.aragonpharmaceuticals.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2009,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "cancer, prostate, therapeutics, discovery-stage, biopharmaceutical, hormone-resistant",
 "alias_list": "",
 "email_address": "info@aragonpharmaceuticals.com",
 "phone_number": "858-369-7600",
 "description": "Hormone-resistant Cancer Treatment",
 "created_at": "Wed Jun 17 21:23:01 UTC 2009",
 "updated_at": "Sun Jun 09 17:34:43 UTC 2013",
 "overview": "\u003Cp\u003EAragon Pharmaceuticals is a discovery-stage small molecule company focused on therapeutics for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       43],
      "assets/images/resized/0004/9225/49225v2-max-150x150.jpg"],
     [[226,
       66],
      "assets/images/resized/0004/9225/49225v2-max-250x250.jpg"],
     [[226,
       66],
      "assets/images/resized/0004/9225/49225v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Executive Vice President of Corporate Strategy Chief Financial Officer",
    "person":
     {"first_name": "Paul",
      "last_name": "Cleveland",
      "permalink": "paul-cleveland",
      "image": null}},
   {"is_past": false,
    "title": "President and Chief Executive Officer",
    "person":
     {"first_name": "Richard",
      "last_name": "Heyman",
      "permalink": "richard-heyman",
      "image": null}},
   {"is_past": false,
    "title": "Chief Medical Officer",
    "person":
     {"first_name": "Isan",
      "last_name": "Chen",
      "permalink": "isan-chen",
      "image": null}},
   {"is_past": false,
    "title": "Board of Director",
    "person":
     {"first_name": "Peter",
      "last_name": "Svennilson",
      "permalink": "peter-svennilson",
      "image": null}},
   {"is_past": false,
    "title": "Board of Director",
    "person":
     {"first_name": "Brett",
      "last_name": "Zbar",
      "permalink": "brett-zbar",
      "image": null}},
   {"is_past": false,
    "title": "Scientific Advisor",
    "person":
     {"first_name": "Charles",
      "last_name": "Sawyers",
      "permalink": "charles-sawyers",
      "image": null}},
   {"is_past": false,
    "title": "Scientific Advisor",
    "person":
     {"first_name": "Ronald",
      "last_name": "M. Evans",
      "permalink": "ronald-m-evans",
      "image": null}},
   {"is_past": false,
    "title": "",
    "person":
     {"first_name": "Peter",
      "last_name": "Svennilson",
      "permalink": "peter-svennilson",
      "image": null}},
   {"is_past": false,
    "title": "Chief Business Officer",
    "person":
     {"first_name": "Angie",
      "last_name": "You",
      "permalink": "angie-you",
      "image": null}},
   {"is_past": false,
    "title": "Board of Director",
    "person":
     {"first_name": "Carl",
      "last_name": "Gordon",
      "permalink": "carl-gordon",
      "image": null}},
   {"is_past": false,
    "title": "Board of Director",
    "person":
     {"first_name": "Carol",
      "last_name": "Gallagher",
      "permalink": "carol-gallagher",
      "image": null}},
   {"is_past": false,
    "title": "Scientific Advisor",
    "person":
     {"first_name": "Jos\u00e9",
      "last_name": "Baselga",
      "permalink": "jos-baselga",
      "image": null}},
   {"is_past": false,
    "title": "Scientific Advisor",
    "person":
     {"first_name": "David",
      "last_name": "J. Mangelsdorf",
      "permalink": "david-j-mangelsdorf",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$122M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://onbiovc.com/aragon-pharmaceuticals-inc-series-a-8m/",
    "source_description": "Aragon Pharmaceuticals, Inc.: Series A $8M",
    "raised_amount": 8000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 5,
    "funded_day": 27,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "The Column Group",
         "permalink": "the-column-group",
         "image":
          {"available_sizes":
            [[[150,
               105],
              "assets/images/resized/0004/9539/49539v1-max-150x150.png"],
             [[230,
               162],
              "assets/images/resized/0004/9539/49539v1-max-250x250.png"],
             [[230,
               162],
              "assets/images/resized/0004/9539/49539v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.fiercebiotech.com/story/aragon-pharma-readies-first-cancer-trial-after-22m-b-round/2010-04-22",
    "source_description": "Aragon Pharma readies first cancer trial after $22M B round ",
    "raised_amount": 22000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 22,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "The Column Group",
         "permalink": "the-column-group",
         "image":
          {"available_sizes":
            [[[150,
               105],
              "assets/images/resized/0004/9539/49539v1-max-150x150.png"],
             [[230,
               162],
              "assets/images/resized/0004/9539/49539v1-max-250x250.png"],
             [[230,
               162],
              "assets/images/resized/0004/9539/49539v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Aisling Capital",
         "permalink": "aisling-capital",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0004/6625/46625v1-max-150x150.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-250x250.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.xconomy.com/san-diego/2012/03/06/san-diegos-aragon-raises-42-million-targets-hormone-driven-cancers/",
    "source_description": "San Diego\u00e2\u20ac\u2122s Aragon Raises $42 Million, Targets Hormone-Driven Cancers",
    "raised_amount": 42000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 3,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Topspin Partners",
         "permalink": "topspin-partners",
         "image":
          {"available_sizes":
            [[[140,
               48],
              "assets/images/resized/0003/0764/30764v1-max-150x150.png"],
             [[140,
               48],
              "assets/images/resized/0003/0764/30764v1-max-250x250.png"],
             [[140,
               48],
              "assets/images/resized/0003/0764/30764v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://www.prnewswire.com/news-releases/aragon-pharmaceuticals-raises-50-million-in-series-d-financing-to-advance-promising-therapeutic-candidates-for-hormone-driven-cancers-172635221.html",
    "source_description": "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers",
    "raised_amount": 50000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 10,
    "funded_day": 4,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "venBio",
         "permalink": "venbio",
         "image":
          {"available_sizes":
            [[[150,
               75],
              "assets/images/resized/0021/4376/214376v1-max-150x150.jpg"],
             [[232,
               116],
              "assets/images/resized/0021/4376/214376v1-max-250x250.jpg"],
             [[232,
               116],
              "assets/images/resized/0021/4376/214376v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Aisling Capital",
         "permalink": "aisling-capital",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0004/6625/46625v1-max-150x150.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-250x250.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "The Column Group",
         "permalink": "the-column-group",
         "image":
          {"available_sizes":
            [[[150,
               105],
              "assets/images/resized/0004/9539/49539v1-max-150x150.png"],
             [[230,
               162],
              "assets/images/resized/0004/9539/49539v1-max-250x250.png"],
             [[230,
               162],
              "assets/images/resized/0004/9539/49539v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "12780 El Camino Real Ste 301",
    "address2": "",
    "zip_code": "92130-2042",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        111],
       "assets/images/resized/0017/7230/177230v1-max-150x150.jpg"],
      [[250,
        185],
       "assets/images/resized/0017/7230/177230v1-max-250x250.jpg"],
      [[450,
        334],
       "assets/images/resized/0017/7230/177230v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}